Potent CD8(+) T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA−NP+M1

Background. Influenza A viruses cause occasional pandemics and frequent epidemics. Licensed influenza vaccines that induce high antibody titers to the highly polymorphic viral surface antigen hemagglutinin must be re-formulated and readministered annually. A vaccine providing protective immunity to...

Descripción completa

Detalles Bibliográficos
Autores principales: Berthoud, Tamara K., Hamill, Matthew, Lillie, Patrick J., Hwenda, Lenias, Collins, Katharine A., Ewer, Katie J., Milicic, Anita, Poyntz, Hazel C., Lambe, Teresa, Fletcher, Helen A., Hill, Adrian V. S., Gilbert, Sarah C.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060888/
https://www.ncbi.nlm.nih.gov/pubmed/21148512
http://dx.doi.org/10.1093/cid/ciq015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060888/
https://www.ncbi.nlm.nih.gov/pubmed/21148512
http://dx.doi.org/10.1093/cid/ciq015

Ejemplares similares